SCHEMBL9682242

SCHEMBL9682242

O=C(O)C1CCC(c2ccccc2)(c2ccccc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
CYP2C9 P11712 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
OPRM1 P35372 3/20 0.45
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
AKR1C1 Q04828 2/20 0.43
AKR1C3 P42330 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
NOTUM Q6P988 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
POLB P06746 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
GRIN1 Q05586 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11572195 0.89 MAPK1 (0.47) MEN1CYP2C9KMT2AMAPK1SMN1; SMN2
SCHEMBL30250167 0.87 AKR1C1 (0.47) MEN1CYP2C9KMT2AOPRM1RAB9A
SCHEMBL30877933 0.85 AKR1C1 (0.46) MEN1CYP2C9KMT2AOPRM1AKR1C1
SCHEMBL9821032 0.85 ESR2 (0.53) CYP2C9RAB9ANPC1LMNACYP2D6
SCHEMBL14379104 0.82 OPRL1 (0.46) OPRM1RAB9ANPC1AKR1C1AKR1C3
SCHEMBL7814234 0.81 RAB9A (0.42) OPRM1RAB9ANPC1AKR1C1AKR1C3
SCHEMBL10477046 0.81 AKR1C1 (0.63) KMT2AOPRM1RAB9ANPC1AKR1C1
Bicarbonate SCHEMBL7575333 0.78 MEN1 (0.60) MEN1CYP2C9KMT2AOPRM1AKR1C1
SCHEMBL5156523 0.78 OPRL1 (0.62) OPRM1
SCHEMBL11573415 0.78 SMN1; SMN2 (0.45) MEN1CYP2C9KMT2AMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175319-A Antiprotozoa agent, useful for treating malaria, theileriosis, coccidiosis and prophylaxix BURROUGHS WELLCOME CO. (US) 1992-12-29 US disclosed
US-5053432-A Antiprotozoa agents; treatment of malaria BURROUGHS WELLCOME CO. (US) 1991-10-01 US disclosed
EP-0123238-B1 NAPHTHOQUINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1987-06-10 EP disclosed
EP-0123238-A2 Naphthoquinone derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1984-10-31 EP disclosed